Martin, A, Murray, L orcid.org/0000-0003-0658-6455, Sethugavalar, B et al. (4 more authors) (2018) Changes in Patient-reported Swallow Function in the Long Term After Chemoradiotherapy for Oropharyngeal Carcinoma. Clinical Oncology, 30 (12). pp. 756-763. ISSN 0936-6555
Abstract
Aims:
To assess long-term patient-reported swallow function after chemoradiotherapy for oropharyngeal carcinoma and to evaluate the frequency of deterioration/improvement over years.
Materials and methods:
Fifty-nine patients with oropharyngeal carcinoma treated with parotid-sparing intensity-modulated radiotherapy and concurrent chemotherapy between 2010 and 2012 had previously completed the MD Anderson Dysphagia Inventory (MDADI) at a median of 34 months (range 24–59) after treatment. An MDADI was posted to 55 alive and disease-free patients after a 30 month interval; 52/55 replies were received, a median of 64 months (range 52–88) after treatment; 27/52 (52%) had been managed with a prophylactic gastrostomy. A 10 point or greater change in the MDADI scores was defined as clinically significant.
Results:
Overall, in the whole cohort, patient-reported swallow function showed a small absolute improvement in MDADI composite score on the second MDADI questionnaire (>5 years after treatment) compared with the first MDADI (>2 years after treatment); mean 68.0 (standard deviation 19.3) versus 64.0 (standard deviation 16.3), P = 0.021. Using the composite score, swallow function was stable over time in 29/52 (56%) patients; a clinically significant improvement in swallow function over time was noted in 17/52 (33%) patients; conversely 6/52 (12%) patients experienced a clinically significant deterioration with time. Abnormality of pre-treatment diet and a prophylactic gastrostomy correlated with an inferior MDADI composite score on the later questionnaire (P = 0.029 and P = 0.044, respectively).
Conclusions:
Long-term dysphagia is prevalent >5 years after treatment. Although long-term swallow function is stable in most patients, it is not static in a minority. On MDADI composite summary scores, 33% of patients experienced an improvement, whereas 12% deteriorated with time. Further investigation is needed to determine underlying mechanisms behind these divergent outcomes.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2018, The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. This is an author produced version of an article published in Clinical Oncology. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | Head and neck cancer; late toxicity; oropharynx cancer; patient-reported outcomes; radiotherapy; swallow function |
Dates: |
|
Institution: | The University of Leeds |
Depositing User: | Symplectic Publications |
Date Deposited: | 08 Nov 2019 11:30 |
Last Modified: | 08 Nov 2019 11:30 |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1016/j.clon.2018.06.013 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:153236 |
Downloads
Filename: MDADI_5yr_paper_v4_revisions_05062018[1].pdf
Licence: CC-BY-NC-ND 4.0